High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial

OBJECTIVES: To determine whether prolonged intensive disease-modifying antirheumatic drug (DMARD) treatment (PRINT) leads to high remission and low relapse rates in patients with severe rheumatoid arthritis (RA). METHODS: In this multicenter, randomized and parallel treatment trial, 346 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ru, Zhao, Jin-Xia, Su, Yin, He, Jing, Chen, Li-Na, Gu, Fei, Zhao, Cheng, Deng, Xue-Rong, Zhou, Wei, Hao, Yan-Jie, Xue, Yu, Liu, Hua-Xiang, Zhao, Yi, Zou, Qing-Hua, Liu, Xiang-Yuan, Zhu, Ping, Sun, Ling-Yun, Zhang, Zhuo-Li, Zou, He-Jian, Li, Xing-Fu, Liu, Yi, Fang, Yong-Fei, Keystone, Edward, McInnes, Iain B., Li, Zhan-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956780/
https://www.ncbi.nlm.nih.gov/pubmed/27428186
http://dx.doi.org/10.1097/MD.0000000000003968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956780/
https://www.ncbi.nlm.nih.gov/pubmed/27428186
http://dx.doi.org/10.1097/MD.0000000000003968

Ejemplares similares